IPG Photonics to acquire Lumibird Medical for €300M; expands medical laser platform

IPG PHOTONICS CORP

Acquires Lumibird Medical for €300M cash-free, debt-free; up to €50M earnout based on 2026-2027 performance.
Lumibird Medical reported FY2025 revenue of €112.2M and EBITDA of €24.1M (21.5% margin).
Deal expected to close in Q4 2026, subject to French works council consultation and FDI approval.
IPG expects the acquisition to be accretive to gross margin, EBITDA, and adjusted EPS; funded with cash on hand.
Adds ~$1B addressable market in medical lasers; creates scaled platform in ophthalmology and urology.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.